Tagged Articles

menopausal 22 articles

Study suggests timing of HRT affects dementia risk

How soon after menopause a woman uses hormone replacement therapy (HRT) may determine her risk for developing dementia, a new study published online in the journal Neurology suggests. The numerous studies conducted on the effects of HRT in women have come to different conclusions about whether the menopause treatment lowers or raises a woman’s risk for Alzheimer’s disease and dementia. Observational studies, or those that follow a group over a period of time, show a reduced risk of dementia in women who use HRT, whereas clinical trials, which test the effects of a drug against placebo, show an increased risk. ... Read More

Dr. Oz warns post-menopausal guest to stay away from HRT

How important is it for a post-menopausal woman to take hormone replacement therapy (HRT)? Audience member Rosemarie posed the question to Dr. Oz, the popular television doctor. Rosemarie says she became post-menopausal three years ago and she has never taken HRT. Hormone replacement therapy was designed to boost hormone levels in menopausal and post-menopausal women and help them deal with symptoms such as irritability, night sweats, hot flashes, vaginal dryness and sleeplessness. If you asked drug companies – especially 20 years ago when HRT was widely prescribed – they would rattle off a laundry list of extra benefits ranging from ... Read More

Tamoxifen with antidepressants may raise risk of breast cancer recurrence

The Food and Drug Administration (FDA) is expected to issue a warming to doctors about an increased risk of the recurrence of breast cancer with patients taking both the breast cancer drug tamoxifen and select antidepressants, according to a study released last week at the American Society of Clinical Oncology’s annual meeting. Researchers at Medco Health Solutions Inc. studied an estimated 1,300 women and found that women who were taking antidepressants such as Paxil, Prozac or Zoloft along with tamoxifen for at least one year had a breast-cancer recurrence rate of 16 percent. Women who were not taking the drugs ... Read More

HRT-breast cancer risk same regardless of family history

Women on hormone replacement therapy (HRT) who have no family history of breast cancer have the same risk of developing breast cancer as women with a family history who are on HRT, according to a University of Rochester Medical Center Study. The study published this week in the Epidemiology journal refutes the notion that a family history contributes to the carcinogenic effects of estrogen. “Although we know that family history is a risk factor, we don’t know yet what it is about family history that conveys the risk,” said Robert E. Gramling, M.D., D.Sc., assistant professor of Family Medicine and ... Read More

Estrogen receptor-positive cancer easier to treat, study says

Hormone replacement therapy (HRT) and its link to breast cancer and other serious conditions continue to make headlines. This week, U.S. News & World Report announced that women who take HRT and then get breast cancer are at lower risk of dying from their disease, according to a new study by the University of California-Irvine. Years ago, HRT was the method-of-choice for most women to combat annoying menopausal symptoms such as hot flashes, moodiness, night sweats and decreased sexual desire. The therapy also was thought to offer other benefits, such as a lowered risk of heart disease and breast cancer. ... Read More

Heavier women suffer more hot flashes, study suggests

Overweight women suffer more hot flashes during menopause than women who maintain a normal weight, according to the Hartford Courant. The news story references a study published by the American Journal of Epidemiology that debunks an earlier belief that menopausal women who were heavier experienced fewer hot flashes than thin women. Hot flashes and night sweats are a common symptom of menopause in most women. While the cause is unknown, researchers believe those symptoms are due to changing levels of estrogen on the temperature regulation centers of the brain. According to the report, when estrogen levels drop during menopause, it ... Read More

Report cites drop in cancer rates among men and women

Two years ago, M.D. Anderson researchers announced a 7 percent drop in breast cancer rates which coincidentally occurred around the same time that women were being told by the media and their doctors of the possible link between hormone replacement therapy (HRT) and serious diseases and conditions such as breast cancer and heart disease. The link was discovered during the Women’s Health Initiative (WHI), a major 15-year research program launched in 1991 to address the most common causes of death, disability and poor quality of life in postmenopausal women – cardiovascular disease, cancer and osteoporosis. The study was halted prematurely ... Read More

Hot flashes, sweats from anti-cancer drugs may be good sign

Women who take breast cancer drugs Arimidex or generic tamoxifen and suffer with menopausal symptoms such as hot flashes, night sweats or painful joints may be less likely to have a reoccurrence of their cancer tumors, according to Reuters. Researchers found that women who took the breast cancer drugs were 30 percent less likely to have their cancer return over the next nine years. The drugs essentially starve potential cancers of estrogen, which can cause menopause-like symptoms in the women who take them. While the side effects may be discouraging, they may also be showing how well the treatment is ... Read More

FDA approves Premarin cream to treat dyspareunia

Wyeth Pharmaceuticals recently announced FDA approval of its Premarin Vaginal Cream to treat moderate to severe dyspareunia, or painful sexual intercourse, according to RTT News. Premarin is a low-dose mixture of estrogen hormones. Dyspareunia is a disorder that follows the atrophy or thinning of the vagina and vulva, a condition that can occur in menopause. The .5-gram cream has two dosing regiments – 21 days on followed by 7 days off, or twice weekly. FDA approval of the cream and its dosing regime was granted based on results from a multi-center clinical study that included a 12-week, randomized, double blind ... Read More

Male hormone increases sex drive, cancer risk questionable

Postmenopausal women who experience a slump in their sex drive may rediscover their libido by taking the male sex hormone testosterone. However, researchers are unsure if there may be a link between the use of testosterone and breast cancer, according to FoodConsumer.org. During menopause, sex drive can drop to very low levels, which some believe may be a result of lowered levels of estrogen, progesterone and testosterone in the body during menopause. Estrogen helps you to feel heightened sensitivity during sexual intercourse. Progesterone keeps your libido up. Testosterone boosts sexual desire and lubricates the vagina. For relief from menopausal symptoms, ... Read More